Correction: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Warren Fiskus, Christopher P. Mill, Christine Birdwell, John A. Davis, Kaberi Das, Steffen Boettcher, Tapan M. Kadia, Courtney D. DiNardo, Koichi Takahashi, Sanam Loghavi, Michael J. Soth, Tim Heffernan, Gerard M. McGeehan, Xinjia Ruan, Xiaoping Su, Christopher R. Vakoc
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAcute Myeloid Leukemia Research · Histone Deacetylase Inhibitors Research · Protein Degradation and Inhibitors
Correction to: Blood Cancer Journal 10.1038/s41408-023-00826-6, published online 13 April 2023
Following the publication of this article an error was noted in Fig. 1. In the original publication, in panel A of Fig. 1, an incorrect Western blot for PBX3 was inadvertently used during the preparation of the figure.
The correct Western blot for PBX3 in panel A of Fig. 1 is presented below. The correction of this figure does not affect the reported results or the conclusions of the article.
The original article has been corrected.